Eric G Carter
CIK 1387660 · Interim Chief Medical Officer · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$71.7K
Companies
6
Total Filings
32
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AEON | Director | 258,705 | $0.28 | $71.7K | $0 | 3 | 2026-06-22 |
| AEON Biopharma, Inc. (AEON.WS) Delisted | Director | — | $1.05 | — | $0 | 2 | 2024-03-21 |
| AEON Biopharma, Inc. (PMGMW) Delisted | Director | — | $0.02 | — | $0 | 1 | 2023-07-24 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 4,800 | $4.36 | $20.9K | $0 | 4 | 2020-06-25 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Interim Chief Medical Officer | — | — | — | $0 | 1 | 2018-04-25 |
| KG | Chief Science Officer | 0 | $8.90 | $0 | $0 | 21 | 2011-02-02 |
Recent Filings · Page 2 of 4
32 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-08 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +48,000 | $0 | EDGAR |
| 2011-02-02 | KG | Mixed | −174,167 | $0 | EDGAR |
| 2011-01-20 | KG | Mixed | +37,940 | $0 | EDGAR |
| 2011-01-20 | KG | Grant (A) | +16,260 | $0 | EDGAR |
| 2011-01-11 | KG | Grant (A) | +16,260 | $0 | EDGAR |
| 2010-12-01 | KG | Tax (F) | −40,426 | -$572.0K | EDGAR |
| 2010-03-31 | KG | Tax (F) | −4,121 | -$50.4K | EDGAR |
| 2010-03-24 | KG | Tax (F) | −1,772 | -$21.7K | EDGAR |
| 2010-03-19 | KG | Grant (A) | +11,970 | $0 | EDGAR |
| 2010-03-01 | KG | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.